BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 31928331)

  • 1. Single-nucleus RNA sequencing reveals transcriptional changes of hippocampal neurons in APP23 mouse model of Alzheimer's disease.
    Zhong S; Wang M; Zhan Y; Zhang J; Yang X; Fu S; Bi D; Gao F; Shen Y; Chen Z
    Biosci Biotechnol Biochem; 2020 May; 84(5):919-926. PubMed ID: 31928331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR elastography detection of early viscoelastic response of the murine hippocampus to amyloid β accumulation and neuronal cell loss due to Alzheimer's disease.
    Munder T; Pfeffer A; Schreyer S; Guo J; Braun J; Sack I; Steiner B; Klein C
    J Magn Reson Imaging; 2018 Jan; 47(1):105-114. PubMed ID: 28422391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The systemic amyloid precursor transthyretin (TTR) behaves as a neuronal stress protein regulated by HSF1 in SH-SY5Y human neuroblastoma cells and APP23 Alzheimer's disease model mice.
    Wang X; Cattaneo F; Ryno L; Hulleman J; Reixach N; Buxbaum JN
    J Neurosci; 2014 May; 34(21):7253-65. PubMed ID: 24849358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholinergic changes in the APP23 transgenic mouse model of cerebral amyloidosis.
    Boncristiano S; Calhoun ME; Kelly PH; Pfeifer M; Bondolfi L; Stalder M; Phinney AL; Abramowski D; Sturchler-Pierrat C; Enz A; Sommer B; Staufenbiel M; Jucker M
    J Neurosci; 2002 Apr; 22(8):3234-43. PubMed ID: 11943824
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and psychological symptoms of dementia (BPSD) and impaired cognition reflect unsuccessful neuronal compensation in the pre-plaque stage and serve as early markers for Alzheimer's disease in the APP23 mouse model.
    Pfeffer A; Munder T; Schreyer S; Klein C; Rasińska J; Winter Y; Steiner B
    Behav Brain Res; 2018 Jul; 347():300-313. PubMed ID: 29572105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-associated neuron loss and gliogenesis in the neocortex of amyloid precursor protein transgenic mice.
    Bondolfi L; Calhoun M; Ermini F; Kuhn HG; Wiederhold KH; Walker L; Staufenbiel M; Jucker M
    J Neurosci; 2002 Jan; 22(2):515-22. PubMed ID: 11784797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BHBA treatment improves cognitive function by targeting pleiotropic mechanisms in transgenic mouse model of Alzheimer's disease.
    Wu Y; Gong Y; Luan Y; Li Y; Liu J; Yue Z; Yuan B; Sun J; Xie C; Li L; Zhen J; Jin X; Zheng Y; Wang X; Xie L; Wang W
    FASEB J; 2020 Jan; 34(1):1412-1429. PubMed ID: 31914599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraneuronal APP and extracellular Aβ independently cause dendritic spine pathology in transgenic mouse models of Alzheimer's disease.
    Zou C; Montagna E; Shi Y; Peters F; Blazquez-Llorca L; Shi S; Filser S; Dorostkar MM; Herms J
    Acta Neuropathol; 2015 Jun; 129(6):909-20. PubMed ID: 25862638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid deposition in APP23 mice is associated with the expression of cyclins in astrocytes but not in neurons.
    Gärtner U; Brückner MK; Krug S; Schmetsdorf S; Staufenbiel M; Arendt T
    Acta Neuropathol; 2003 Dec; 106(6):535-44. PubMed ID: 12923647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APP23 mice as a model of Alzheimer's disease: an example of a transgenic approach to modeling a CNS disorder.
    Van Dam D; Vloeberghs E; Abramowski D; Staufenbiel M; De Deyn PP
    CNS Spectr; 2005 Mar; 10(3):207-22. PubMed ID: 15744222
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age effects on the regulation of adult hippocampal neurogenesis by physical activity and environmental enrichment in the APP23 mouse model of Alzheimer disease.
    Mirochnic S; Wolf S; Staufenbiel M; Kempermann G
    Hippocampus; 2009 Oct; 19(10):1008-18. PubMed ID: 19219917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impairment of adolescent hippocampal plasticity in a mouse model for Alzheimer's disease precedes disease phenotype.
    Hartl D; Rohe M; Mao L; Staufenbiel M; Zabel C; Klose J
    PLoS One; 2008 Jul; 3(7):e2759. PubMed ID: 18648492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dispersible amyloid β-protein oligomers, protofibrils, and fibrils represent diffusible but not soluble aggregates: their role in neurodegeneration in amyloid precursor protein (APP) transgenic mice.
    Rijal Upadhaya A; Capetillo-Zarate E; Kosterin I; Abramowski D; Kumar S; Yamaguchi H; Walter J; Fändrich M; Staufenbiel M; Thal DR
    Neurobiol Aging; 2012 Nov; 33(11):2641-60. PubMed ID: 22305478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased hippocampal neurogenesis in the progressive stage of Alzheimer's disease phenotype in an APP/PS1 double transgenic mouse model.
    Yu Y; He J; Zhang Y; Luo H; Zhu S; Yang Y; Zhao T; Wu J; Huang Y; Kong J; Tan Q; Li XM
    Hippocampus; 2009 Dec; 19(12):1247-53. PubMed ID: 19309037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired hypoxic tolerance and altered protein binding of NADH in presymptomatic APP23 transgenic mice.
    Büchner M; Huber R; Sturchler-Pierrat C; Staufenbiel M; Riepe MW
    Neuroscience; 2002; 114(2):285-9. PubMed ID: 12204198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p38 MAP kinase-mediated NMDA receptor-dependent suppression of hippocampal hypersynchronicity in a mouse model of Alzheimer's disease.
    Ittner AA; Gladbach A; Bertz J; Suh LS; Ittner LM
    Acta Neuropathol Commun; 2014 Oct; 2():149. PubMed ID: 25331068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic Cerebral Hypoperfusion Activates the Coagulation and Complement Cascades in Alzheimer's Disease Mice.
    Shi X; Ohta Y; Liu X; Shang J; Morihara R; Nakano Y; Feng T; Huang Y; Sato K; Takemoto M; Hishikawa N; Yamashita T; Abe K
    Neuroscience; 2019 Sep; 416():126-136. PubMed ID: 31394196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aging, microglia and cytoskeletal regulation are key factors in the pathological evolution of the APP23 mouse model for Alzheimer's disease.
    Janssen L; Dubbelaar ML; Holtman IR; de Boer-Bergsma J; Eggen BJ; Boddeke HW; De Deyn PP; Van Dam D
    Biochim Biophys Acta Mol Basis Dis; 2017 Feb; 1863(2):395-405. PubMed ID: 27838490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Telomere shortening reduces Alzheimer's disease amyloid pathology in mice.
    Rolyan H; Scheffold A; Heinrich A; Begus-Nahrmann Y; Langkopf BH; Hölter SM; Vogt-Weisenhorn DM; Liss B; Wurst W; Lie DC; Thal DR; Biber K; Rudolph KL
    Brain; 2011 Jul; 134(Pt 7):2044-56. PubMed ID: 21672962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular amyloid formation and associated pathology in neural grafts.
    Meyer-Luehmann M; Stalder M; Herzig MC; Kaeser SA; Kohler E; Pfeifer M; Boncristiano S; Mathews PM; Mercken M; Abramowski D; Staufenbiel M; Jucker M
    Nat Neurosci; 2003 Apr; 6(4):370-7. PubMed ID: 12598899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.